![Alexis Denis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexis Denis worked as a Director of Medicinal Chemistry at Mutabilis SA from 2009 to 2011.
Later, from 2016 to 2020, he worked as a Director of Discovery Division at Oncodesign SA. Prior to his work experience, he earned a doctorate degree from Université Pierre et Marie Curie.
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCODESIGN | Corporate Officer/Principal | 01-07-2020 |
Mutabilis SA
 Mutabilis SA Pharmaceuticals: MajorHealth Technology Develops antibiotics and antibacterial therapies | Hoofd Techniek/Wetenschap/O&O | 24-12-2009 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Mutabilis SA
Mutabilis SA Pharmaceuticals: MajorHealth Technology Develops antibiotics and antibacterial therapies | Health Technology |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncodesign SA
 Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
